Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia

CEFEPIME AND AMIKACIN AS EMPIRICAL THERAPY IN PATIENTS WITH FEBRILE NEUTROPAENIA: A SINGLE-CENTRE PHASE II PROSPECTIVE SURVEY

(2014) J. Mebis et al.   ACTA CLINICA BELGICA

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

Co-resistance: an opportunity for the bacteria and resistance genes

(2011) Rafael Cantón et al.   CURRENT OPINION IN PHARMACOLOGY

Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: Results of a single institution, randomized phase 2 trial

(2010) Evangelos Eleutherakis-Papaiakovou et al.   AMERICAN JOURNAL OF HEMATOLOGY

Perils of quinolone exposure in cancer patients

(2010) Gopi Rangaraj et al.   CANCER

Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change

(2010) Mebis   Infection and Drug Resistance

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

(2009) M Tomblyn et al.   BONE MARROW TRANSPLANTATION

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

(2009) R Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Strategies for minimizing complications of neutropenia: Prophylactic myeloid growth factors or antibiotics

(2009) John R. Wingard et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY